What to expect when you take Celecoxib and Oxybutynin chloride?

Do you take Celecoxib and Oxybutynin chloride? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Jun, 23, 2018

21,442 reports have been studied.


Females aged 50 to 59 :

15,152 related reports were analyzed:

Most common symptoms:

Chest pain
  • 5.05% for females aged 50 (±5) who take Oxybutynin chloride
Depression
  • 5.49% for females aged 50 (±5) who take Oxybutynin chloride
Dizziness
  • 6.34% for females aged 50 (±5) who take Oxybutynin chloride
Drug ineffective
  • 8.41% for females aged 50 (±5) who take Celecoxib
Fall
  • 10.54% for females aged 50 (±5) who take Oxybutynin chloride
Fatigue (feeling of tiredness)
  • 6.7% for females aged 50 (±5) who take Oxybutynin chloride
  • 5.43% for females aged 50 (±5) who take Celecoxib
Gait disturbance
  • 5.69% for females aged 50 (±5) who take Oxybutynin chloride
Headache (pain in head)
  • 5.62% for females aged 50 (±5) who take Celecoxib
  • 5.33% for females aged 50 (±5) who take Oxybutynin chloride
Joint pain
  • 6.9% for females aged 50 (±5) who take Celecoxib
Nausea (feeling of having an urge to vomit)
  • 7.67% for females aged 50 (±5) who take Oxybutynin chloride
  • 7.61% for females aged 50 (±5) who take Celecoxib
Pain
  • 8.57% for females aged 50 (±5) who take Celecoxib
  • 5.78% for females aged 50 (±5) who take Oxybutynin chloride
Stress and anxiety
  • 5.74% for females aged 50 (±5) who take Celecoxib
Urinary tract infection
  • 8.36% for females aged 50 (±5) who take Oxybutynin chloride
Weakness
  • 8.08% for females aged 50 (±5) who take Oxybutynin chloride

Most common co-existing conditions:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
  • 10.11% for females aged 50 (±5) who take Celecoxib
Depression
  • 8.4% for females aged 50 (±5) who take Oxybutynin chloride
High blood pressure
  • 6.71% for females aged 50 (±5) who take Celecoxib
  • 5.21% for females aged 50 (±5) who take Oxybutynin chloride
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  • 28.11% for females aged 50 (±5) who take Oxybutynin chloride
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  • 18.22% for females aged 50 (±5) who take Celecoxib
back to top

Males aged 50 to 59 :

6,290 related reports were analyzed:

Most common symptoms:

Chest pain
  • 5.24% for males aged 50 (±5) who take Celecoxib
Diarrhea
  • 5.74% for males aged 50 (±5) who take Oxybutynin chloride
Dizziness
  • 7.4% for males aged 50 (±5) who take Oxybutynin chloride
Drug ineffective
  • 5.99% for males aged 50 (±5) who take Celecoxib
Fall
  • 5.74% for males aged 50 (±5) who take Oxybutynin chloride
Fatigue (feeling of tiredness)
  • 8.16% for males aged 50 (±5) who take Oxybutynin chloride
Heart attack
  • 14.52% for males aged 50 (±5) who take Celecoxib
High blood pressure
  • 5.89% for males aged 50 (±5) who take Oxybutynin chloride
  • 5.49% for males aged 50 (±5) who take Celecoxib
Nausea (feeling of having an urge to vomit)
  • 6.5% for males aged 50 (±5) who take Oxybutynin chloride
Pain
  • 6.19% for males aged 50 (±5) who take Oxybutynin chloride
  • 5.74% for males aged 50 (±5) who take Celecoxib
Rashes (redness)
  • 5.44% for males aged 50 (±5) who take Oxybutynin chloride
Urinary tract infection
  • 6.65% for males aged 50 (±5) who take Oxybutynin chloride
Weakness
  • 5.59% for males aged 50 (±5) who take Oxybutynin chloride

Most common co-existing conditions:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
  • 12.47% for males aged 50 (±5) who take Celecoxib
Depression
  • 5.14% for males aged 50 (±5) who take Oxybutynin chloride
High blood pressure
  • 7.1% for males aged 50 (±5) who take Oxybutynin chloride
  • 6.17% for males aged 50 (±5) who take Celecoxib
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  • 22.05% for males aged 50 (±5) who take Oxybutynin chloride
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  • 9.86% for males aged 50 (±5) who take Celecoxib
back to top

Related studies

Celecoxib

Celecoxib has active ingredients of celecoxib. It is often used in osteoarthritis. (latest outcomes from Celecoxib 14,443 users)

Oxybutynin chloride

Oxybutynin chloride has active ingredients of oxybutynin chloride. It is often used in urge incontinence. (latest outcomes from Oxybutynin chloride 4,797 users)

Celecoxib and Oxybutynin chloride

Analysis tools (to study 526 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Celecoxib, Oxybutynin chloride

Recent updates

General studies
Active Support Groups
Recent Predictions

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.